Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
9,830 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Individualized Homoeopathy Added to Standard Pharmacological Care for Migraine: A Pragmatic Randomized Open-Label Blinded-Endpoint Controlled Trial.
Prasad S, Ratnasabapathy E, Venkatesan H, Ramalingam S. · Clin Ter · 2026 · cited 0 timesclinical trial, randomized controlled trial
- Effects of Probiotics on Migraine in Children and Adults: A Systematic Review and Meta-Analysis.
Gasner N, Sweeney M, Piché JV, Doja A, Bonakdar R. · Curr Pain Headache Rep · 2026 · cited 0 timesmeta-analysis, systematic review
- Migraine and the risk of glaucoma: a systematic review and meta-analysis.
Lu S, Ye X, Chen S, Zhang J, Sun T, Lin X. · Front Neurol · 2026 · cited 0 timesmeta-analysis, systematic review
- Resting-state fMRI correlates of acupuncture in migraine: a coordinate-based meta-analysis.
Liu GY, Li LH, Cao ZM, Chen Z, Wang ZC, Yuan YK, Yan CQ, Wang J. · J Oral Facial Pain Headache · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Cognitive impairment in vestibular migraine: a PubMed-based systematic review and meta-analysis.
Di M, Hu L, Li C, Yin X, Gui S, Han L. · Front Neurol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Depressive and anxiety symptoms during CGRP-targeted migraine prevention: A systematic review and meta-analysis.
Al-Sayegh Z, Al-Khazali S, Al-Khazali HM, Christensen RH, Videbech P, Lipton RB, Schytz HW. · Cephalalgia · 2026 · cited 0 timesmeta-analysis, systematic review
- Exploring Proximal and Distal Ultrasound-Guided Greater Occipital Nerve Block Approaches in Migraine: A Systematic Review and Meta-Analysis.
Sabet H, Samir A, Lashin B, Abbas A, Ramadan S, El-Moslemani M, Younis AF, Yousef O, Rouby RA, Abd-Elsayed A. · Pain Pract · 2026 · cited 0 timesmeta-analysis, systematic review
- Digital screen exposure and migraine burden: a systematic review and meta-analysis.
Gowda N, Harish S, Tej G. · J Neurol · 2026 · cited 0 timesmeta-analysis, systematic review
- Efficacy and cardiovascular safety of lasmiditan in patients with cardiovascular risk factors: A systematic review and meta-analysis with updated synthesis of triptan safety data.
Biswas S, Vasireddy S, Srivastava Y, Gehlot D, Fasil C, Natarajan HA, Reza IMK, Youn J, Bajaj NG, Hussain Z, Singh S, Ushodaya G, Altabawi M, Shankar A. · Headache · 2026 · cited 0 timesmeta-analysis, systematic review
- Cervical strengthening and stabilization exercises in migraine management: A systematic review.
Burus J, O'Dell DR, Robinson C, Holt A, Hoch JM. · Cephalalgia · 2026 · cited 0 timesmeta-analysis, systematic review
- Sustained response to atogepant in episodic and chronic migraine: Post-hoc analyses of ELEVATE and PROGRESS, and their open-label extension.
Cho SJ, Friedman DI, Chalermpalanupap N, Nahas SJ, Dabruzzo B, Najib U, Liu Y, Carr K, Sakai F, Smith JH, Pozo-Rosich P. · Cephalalgia · 2026 · cited 0 timesrandomized controlled trial
- Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis.
Mitra A, Franks B, Petruschke R, Dhiman A, Bansal N. · Front Neurol · 2026 · cited 0 timesOpen accesscomparative study, systematic review
- Restless legs syndrome and other neurological disorders: A systematic-narrative hybrid literature review with exploratory meta-analysis.
Hawas Y, Abo-Elnour DE, Al-Hawari NEM, Gahlan S, Winkelman JW. · Sleep Med Rev · 2026 · cited 0 timesmeta-analysis, systematic review
- Iatrogenic harm in paediatric and adolescent populations of patients with migraine: A systematic review with meta-analysis.
Montisano DA, Giulia G, Alessia M, Barbara C, Licia G, Alberto R, Alessandra P. · Cephalalgia · 2026 · cited 0 timesmeta-analysis, systematic review
- Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial.
Ronquest N, Zhang Y, Park TJ, Campbell K, Anderson S. · J Med Econ · 2026 · cited 0 timesrandomized controlled trial
- Magnitude and Determinants of Placebo Response in Acute Migraine Trials: A Systematic Review and Meta-Analysis.
Makita LM, Katsuyama E, Christensen RH, Takeshima T, Ashina S, Piovesan EJ, Luna AM, Ueda GN, Antunes VDLJ, Sahin OK, Miguita ALP, Hakkeem B, Fagundes TP, Talah BAD, Peres MFP. · Neurology · 2026 · cited 0 timesmeta-analysis, systematic review
- Targeting TRPA1 antagonists for nociplastic pain: systematic review and meta-analysis of preclinical evidence.
Antoniazzi C, Brito HA, Rodrigues P, Vione Fim Y, Ruviaro NA, Machado AC, Trevisan G. · Eur J Pharmacol · 2026 · cited 0 timesmeta-analysis, systematic review
- Placebo Effect of Verbal Instructions Coupled with Pharmacological Treatment: Results from a Randomized Controlled Trial in Migraine Patients.
Romanazzo S, Monti F, Ceccatelli S, De Cesaris F, Chiarugi A, Cosci F. · Psychother Psychosom · 2026 · cited 0 timesrandomized controlled trial
- The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis.
Riise HS, Thorvik H, Øie LR, Stovner LJ, Tronvik EA, Linde M, Hagen K, Giri S, Wergeland T. · Cephalalgia · 2026 · cited 1 timesmeta-analysis, systematic review
- Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.
Kim K, Kim K, Cho SY, Kwon Y, Kim WK, Lim C, Cho WH, Kim D, Kim YH, Song TJ. · Headache · 2026 · cited 0 timesmeta-analysis, systematic review
- Regulatory T cell levels in migraine: A systematic review and meta-analysis.
Stuchfield-Denby E, Adelou S, Moisset X, Dallel R. · J Headache Pain · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Efficacy and Safety of 2 Rimegepant Dosing Regimens for the Prevention of Episodic Migraine: A Randomized Controlled Study.
Goadsby PJ, Tassorelli C, Fountaine RJ, Antinew J, de Besi P, Dubrovin S, Russell K, Kopf SR, Hughes JH, Loprinzo V, Fullerton T. · Neurology · 2026 · cited 0 timesim, multicenter study
- Early improvements in function with atogepant as assessed by the Activity Impairment in Migraine-Diary: Post hoc analyses of three randomized, phase 3 clinical trials of atogepant for the preventive treatment of migraine.
Lipton RB, Gandhi P, Gantenbein AR, Dabruzzo B, Carr K, Stokes J, Duan M, Halker Singh RB, Yuan H, Buse DC. · Headache · 2026 · cited 0 timesOpen accessclinical trial, phase iii, multicenter study
- Fremanezumab for migraine in clinical practice: a systematic review and meta-analysis.
Fernández-Bravo-Rodrigo J, Pascual-Morena C, Saz-Lara A, Martínez-García I, Lever-Megina CG, Patiño-Cardona S, Flor-García A, Cavero-Redondo I. · Expert Rev Neurother · 2026 · cited 1 timesmeta-analysis, systematic review
- The Efficacy and Safety of Rimegepant Every Other Day as Preventive Treatment for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Attar A, Alqsair A, Halabi M, Barwais K, Alzaid A, Alshaikhi R, Alamri L, Aljadani H, Alsharif J, Zagzoog N, Aladdin Y. · Curr Pain Headache Rep · 2026 · cited 0 timesmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.